CRT-100.61 Clinical and Prescribing Outcomes in a Predominantly Minority Population Undergoing Percutaneous Coronary Intervention and CYP2C19 Genotyping.

MLA

Lee, James C., et al. “CRT-100.61 Clinical and Prescribing Outcomes in a Predominantly Minority Population Undergoing Percutaneous Coronary Intervention and CYP2C19 Genotyping.” JACC: Cardiovascular Interventions, vol. 13, Feb. 2020, p. S16. EBSCOhost, https://doi.org/10.1016/j.jcin.2020.01.044.

APA

Lee, J. C., Han, J., Kadkol, S. S., Shroff, A. R., Groves, E. M., & Ardati, A. K. (2020). CRT-100.61 Clinical and Prescribing Outcomes in a Predominantly Minority Population Undergoing Percutaneous Coronary Intervention and CYP2C19 Genotyping. JACC: Cardiovascular Interventions, 13, S16. https://doi.org/10.1016/j.jcin.2020.01.044

Chicago

Lee, James C., Jin Han, Shrihari S. Kadkol, Adhir R. Shroff, Elliott M. Groves, and Amer K. Ardati. 2020. “CRT-100.61 Clinical and Prescribing Outcomes in a Predominantly Minority Population Undergoing Percutaneous Coronary Intervention and CYP2C19 Genotyping.” JACC: Cardiovascular Interventions 13 (February): S16. doi:10.1016/j.jcin.2020.01.044.